Clinical Trial Update: Lisdexamfetamine's Effect In ADHD in the Brain and Cognition [Phase 4]

View source ↗

Summary

Phase 4 trial update on lisdexamfetamine in ADHD; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Lisdexamfetamine (lisdexamfetamine dimesylate)

Snippet

Sponsor: University of California, Davis | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: TERMINATED | Results posted: 2019-12-26